This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Analysis Of The United States Bone Grafts And Bone Graft Substitutes Market

NEW YORK, April 2, 2013 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Analysis of the United States Bone Grafts and Bone Graft Substitutes Market http://www.reportlinker.com/p01075846/Analysis-of-the-United-States-Bone-Grafts-and-Bone-Graft-Substitutes-Market.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Orthopedic

This research service considers products and companies in the bone grafts and bone graft substitutes market in the United States. This market expects to witness many technology advancements in the next decade. A thorough analysis of revenue forecasts, unit forecasts, technological advances, and pricing are provided for the market's various segments including: machine allografts, standard allografts, demineralized bone matrix, bone morphogenetic proteins (BMP), bone graft substitutes, and platelet concentration systems markets. Market engineering measurements, drivers, and restraints are covered along with an analysis of the market's highly competitive landscape. The base year is 2011; the forecast period extends through 2016.

Executive Summary•Total revenue generated by sales of bone grafts and bone graft substitutes in the United States (U.S.) in 2011 was approximately $xxmillion, representing a xx percent decrease over 2010.•Revenue in the U.S. bone grafts and bone graft substitute market is projected to grow at a compound annual growth rate (CAGR) ofxx percent from 2011 to 2016, reaching $xx million in 2016.•The segment with the highest CAGR is the cell-based matrices market, followed closely by the demineralized bone matrix (DBM) market.•The decrease in the growth rate for the bone morphogenetic protein (BMP) market has been one of the biggest factors leading to the decline in the overall market. This is the largest segment in the entire market.•As new clinical data is published and innovation continues, the market is expected to slowly get back to larger market growth numbers.•The market is mostly controlled by large manufacturers, but there are low barriers to entries in the niche segments.

TABLE OF CONTENTS Executive Summary 4Market Overview 9Total Bone Grafts and Bone Graft Substitutes Market -•External Challenges: Drivers and Restraints 19•Forecast and Trends 28•Competitive Analysis 36Machined Bone Allograft Segment Breakdown 41Standard Bone Allograft Segment Breakdown 52DBM Segment Breakdown 63Bone Graft Substitutes Segment Breakdown 75BMP Segment Breakdown 91Cell-based Matrices Segment Breakdown 104Platelet Concentration System Segment Breakdown 116The Last Word (Conclusions and Implications) 127Appendix 129

To order this report:: Analysis of the United States Bone Grafts and Bone Graft Substitutes Market

 

1 of 2

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!

Markets

DOW 18,030.21 +6.04 0.03%
S&P 500 2,081.88 -0.29 -0.01%
NASDAQ 4,773.4720 +8.0480 0.17%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs